
Sign up to save your podcasts
Or
RealTalk MS Reaches a Milestone :26
Join the RealTalk MS Conversation :48
Living with MS? Your Access to Healthcare is Under Attack ...Again! 2:53
Mavenclad Receives FDA Approval for Treating Relapsing-Remitting and Active Secondary Progressive MS 11:37
Siponimod Receives FDA Approval for Treating Relapsing-Remitting and Active Secondary Progressive MS 15:01
Celgene Submits Application for FDA Approval of Ozanimod for Treating Relapsing-Remitting MS 16:41
My Interview with Dr. Valerie Block 19:16
Download the Free RealTalk MS App 34:04
___________
ADD YOUR VOICE TO THE CONVERSATION
I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes.
Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!
Email: [email protected]Phone: (310) 526-2283
___________
LINKS
If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com
Download the RealTalk MS App for iOS
Download the RealTalk MS App for Android
Give RealTalk MS a Rating & Review
26 Patient Groups Support Bill to Stabilize and Strengthen the Affordable Care Act FDA Approves New Oral Treatment for Multiple Sclerosis FDA Approves New Oral Drug to Treat Multiple Sclerosis___________
Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.
RealTalk MS Episode 84 Hosted By: Jon Strum Guest: Dr. Valerie Block
Tags: MS, MultipleSclerosis, MSResearch, ProgressiveMS, Mavenclad, EMDSerono, Siponimod, Novartis, Celgene, RealTalkMS
4.7
139139 ratings
RealTalk MS Reaches a Milestone :26
Join the RealTalk MS Conversation :48
Living with MS? Your Access to Healthcare is Under Attack ...Again! 2:53
Mavenclad Receives FDA Approval for Treating Relapsing-Remitting and Active Secondary Progressive MS 11:37
Siponimod Receives FDA Approval for Treating Relapsing-Remitting and Active Secondary Progressive MS 15:01
Celgene Submits Application for FDA Approval of Ozanimod for Treating Relapsing-Remitting MS 16:41
My Interview with Dr. Valerie Block 19:16
Download the Free RealTalk MS App 34:04
___________
ADD YOUR VOICE TO THE CONVERSATION
I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes.
Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!
Email: [email protected]Phone: (310) 526-2283
___________
LINKS
If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com
Download the RealTalk MS App for iOS
Download the RealTalk MS App for Android
Give RealTalk MS a Rating & Review
26 Patient Groups Support Bill to Stabilize and Strengthen the Affordable Care Act FDA Approves New Oral Treatment for Multiple Sclerosis FDA Approves New Oral Drug to Treat Multiple Sclerosis___________
Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.
RealTalk MS Episode 84 Hosted By: Jon Strum Guest: Dr. Valerie Block
Tags: MS, MultipleSclerosis, MSResearch, ProgressiveMS, Mavenclad, EMDSerono, Siponimod, Novartis, Celgene, RealTalkMS
1,707 Listeners
502 Listeners
4,930 Listeners
111,864 Listeners
14,233 Listeners
13 Listeners
47 Listeners
309 Listeners
116 Listeners
8,210 Listeners
57,990 Listeners
111 Listeners
10,447 Listeners
10,459 Listeners
3,521 Listeners